-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Relay Therapeutics, Inc. quarterly and annual Revenue from Contract with Customer, Excluding Assessed Tax in USD history and change rate from 31 Dec 2020 to 31 Dec 2025.
- Relay Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 31 Dec 2025 was $6,999,000.
- Relay Therapeutics, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the twelve months ending 31 Dec 2025 was $15,355,000, a 53% increase year-over-year.
- Relay Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2025 was $15,355,000, a 53% increase from 2024.
- Relay Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $10,007,000, a 61% decline from 2023.
- Relay Therapeutics, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $25,546,000, a 1750% increase from 2022.